‘Barbenheimer’ gets off to hot start with $32.8 million in combined Thursday sales

‘Barbenheimer’ gets off to hot start with .8 million in combined Thursday sales


Cillian Murphy in Oppenheimer and Margot Robbie as Barbie

Julien De Rosa | AFP | Getty Images; Stuart C. Wilson | Getty Images

“Barbenheimer” is off to a red-hot start at the domestic box office.

One-half of the viral internet meme, “Barbie,” snared $22.3 million in Thursday night preview tickets, the most of any film released so far in 2023 – topping the $17.4 million bow of Sony’s “Spider-Man: Across the Spider-Verse.”

The R-rated, three-hour “Oppenheimer,” meanwhile, tallied $10.5 million from Thursday showings. That’s in line with big releases such as 2017’s “Wonder Woman” and this year’s live action “The Little Mermaid.”

Heading into the weekend, Warner Bros.’ “Barbie” is expected to capture upwards of $140 million, if not more, over its first three days in theaters. Meanwhile, Universal’s “Oppenheimer” appears destined to snare at least $50 million, with some box office analysts expecting it could top $60 million.

The two films could together generate $200 million over their opening frame. With additional ticket sales from “Mission: Impossible — Dead Reckoning Part One,” “Spider-Man: Across the Spider-Verse” and “Sound of Freedom,” it could be the highest-grossing weekend of the year so far.

This excitement is much needed for the domestic box office after a string of recently released big-budget movies, such as “The Flash” and “Indiana Jones and the Dial of Destiny,” fell short of expectations.

Major movie chains have indicated that ticket sales are strong for both films this weekend and additional shows have been added to accommodate demand.

Some 40,000 AMC Theatre loyalty program members have purchased tickets to see Barbie and Oppenheimer on the same day and the National Association of Theatre owners project that more than 200,000 moviegoers will attend same-day viewings of the two films.

Disclosure: Comcast is the parent company of NBCUniversal and CNBC.



Source

Moderna says FDA refuses to review its application for experimental flu shot
Business

Moderna says FDA refuses to review its application for experimental flu shot

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration has refused to start a review of Moderna‘s application for its experimental flu shot, the company announced Tuesday, in another sign of the […]

Read More
Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products
Business

Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products

Walmart Inc. signage during the company’s listing at the Nasdaq MarketSite in New York, US, on Tuesday, Dec. 9, 2025. Michael Nagle | Bloomberg | Getty Images Estee Lauder sued Walmart in California federal court over allegations the big-box retailer sold counterfeit beauty products on its website and didn’t do enough to ensure only authorized […]

Read More
How this French building behemoth wants to solve the U.S. housing dilemma
Business

How this French building behemoth wants to solve the U.S. housing dilemma

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. French […]

Read More